This course will provide a comprehensive review of topics in the evaluation and management of patients with lung cancer. We will start with an outstanding international example of tobacco control, discuss guidelines and practical tips for lung cancer screening, the new staging system and use of biomarkers for lung cancer detection and disease progression. The treatment of early stage, locally advanced and metastatic disease will be addressed, highlighting novel/minimally invasive approaches as well as the use, and toxicities of immunotherapy. Advancements in the evaluation and treatment of carcinoid and atypical carcinoid will also be highlighted. Interactive tumor boards will be held to highlight main teaching points and facilitate audience engagement.
CME credits and/or Certificates of Completion are not provided for this session.
1- Improve the use of CT screening in your practice setting/community
2- Integrate new treatment options for patients with stage III lung cancer
3- Gain new findings about the toxicities of immunotherapy
Panagis Galiatsatos, DrMed: BIG Tobacco and Electronic Nicotine Delivery Systems: Preventing Another Epidemic
Renda S. Wiener, MD, MPH: Lung Cancer Screening: The Data and the Disconnect
Anne Valerie. Gonzalez, MD, MSc, MUHC: Lung Cancer Staging: Past, Present, and Future
Kazuhiro Yasufuku, MD: Pro/Con: Surgery Remains the Best Option for Early Stage Disease
James Urbanic, MD: SBRT Is the Best Option for Early Stage Disease
Frank Detterbeck, MD: The Heterogeneity of Stage III Disease
Tobias Peikert, MD: The Good: Immunotherapy in Lung Cancer from Neo-Adjuvant to Advanced-Stage Disease
Karthik Suresh, MD: The Bad: Recognizing and Managing Immune-Related Toxicity
Shetal Patel, MD, MSc: Targeted Therapy in Stage IV Disease
M. Patricia Rivera, MD, ATSF: Oligometastatic Disease
David J. Feller-Kopman, MD, DHMC: Typical and Atypical Carcinoid
Sandip P. Patel, MD. : Lung Cancer in the Elderly, Minority and Female Populations
You can save 20% today by joining the ATS. Join more than 16,000 healthcare providers and researchers as a member of the American Thoracic Society today. As an ATS member, you’ll gain access to cutting-edge science, collaboration opportunities, discounts on the annual ATS International Conference, and resources to share with patients. The ATS offers multiple ways to get involved, from Assembly membership to in-person networking opportunities, as well as an online community offered through DocMatter. Join the ATS Today!